Investigacion Farmaceutica S.A. DE C.V.
MexicoFDA applicant, unverified
- Devices
- 24
What Investigacion Farmaceutica S.A. DE C.V. makes
The company manufactures in vitro diagnostic (IFA) tests for antibiotic susceptibility, including assays for bacitracin, penicillin, imipenem, cephalotin, tetracycline, streptomycin, nalidixic acid, gentamicin, norfloxacin, and polymyxin B, as well as diagnostic tests for *Proteus* OX-19 and *Brucella* antigens.
These products are regulated under FDA’s Class I and Class II device classifications, with some submissions recorded via the 510(k) pathway. The company’s diagnostics are listed in the FDA’s 510(k) registry, and the manufacturer is based in the United States.
Catalogue
Search and filter all 24 devicesFrequently asked questions
How many devices does Investigacion Farmaceutica S.A. DE C.V. have in the registry?
The registry currently lists 24 devices for Investigacion Farmaceutica S.A. DE C.V.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Investigacion Farmaceutica S.A. DE C.V.'s devices?
Among its 24 most recently registered devices, Investigacion Farmaceutica S.A. DE C.V. has devices listed in FDA 510(k) (24 devices).
What risk classes do Investigacion Farmaceutica S.A. DE C.V.'s devices fall under?
Among its 24 most recently registered devices, the classes recorded for Investigacion Farmaceutica S.A. DE C.V.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Investigacion Farmaceutica S.A. DE C.V. in the registry?
The most recently registered devices listed for Investigacion Farmaceutica S.A. DE C.V. include IFA SENSIBAC BACITRACIN, IFA SENSIBAC PENICILLIN, IFA SENSIBAC INIPENEM and IFA SENSIBAC CEPHALOTIN.